Table 3.
Pearson’s correlation analysis between glucosinolate compounds.
| SIN | GNA | GBN | PRO | GTL | GER | GNS | GBE | GBB | |
|---|---|---|---|---|---|---|---|---|---|
| GNA | 0.625 *** | ||||||||
| GBN | 0.759 *** | 0.652 *** | |||||||
| PRO | 0.502 *** | 0.531 *** | 0.358 *** | ||||||
| GTL | −0.217 | −0.227 | −0.010 | −0.203 | |||||
| GER | 0.210 | 0.183 | 0.038 | 0.382 ** | −0.122 | ||||
| GNS | 0.734 *** | 0.683 *** | 0.627 *** | 0.756 *** | −0.238 * | 0.424 ** | |||
| GBE | 0.544 *** | 0.312 * | 0.481 | 0.272 * | 0.015 | 0.573 *** | 0.529 *** | ||
| GBB | 0.224 | 0.345 * | 0.443 | 0.247 | 0.195 | 0.343 | 0.430 * | 0.540 *** | |
| GBS | 0.531 *** | 0.274 * | 0.516 *** | 0.243 | 0.144 | 0.224 | 0.466 * | 0.601 *** | 0.347 ** |
*, **, *** Correlationship is significant at p ≤ 0.05, 0.01, and 0.001, respectively. Glucobarbarin (GBB), glucoberteroin (GBE), glucobrassicanapin (GBN), glucobrassicin (GBS), glucoerucin (GER), gluconapin (GNA), gluconasturtiin (GNS), glucotropaeolin (GTL), progoitrin (PRO), and Sinigrin (SIN).